Whilst on it own the references to "advanced discussions is positive - and I firmly believe the outcome will be beneficial to holders. pushing the time frame from Q4 18 to Q2 19 (i.e. potentially missing by 6 months) does show some immaturity in understanding the complexities of this and future deals.
IMO, the company could do with some additional expertise in the pre-planning and execution of future deals. The market may accept this missed time frame (pending the quality of the deal) - but I wouldn't imagine there will be too many more such instances accepted. Lesson being - if you are not sure - don;t nominate a time frame - stick to "near future".
"Working closely with AGC and the Company’s Japanese advisors, it is anticipated that a licence agreement will be secured in Q2 FY19. The licensee will be responsible for the sponsorship and funding of the Company’s Phase 2 trial of Progenza for osteoarthritis and its commercialisation in Japan and will mark a significant next milestone in the Company’s progress towards commercialisation."
- Forums
- ASX - By Stock
- CMB
- Ann: FY18 Results and Business Update
Ann: FY18 Results and Business Update, page-4
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CMB (ASX) to my watchlist
(20min delay)
|
|||||
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.368M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 52731 | 45.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
48.0¢ | 24 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 52731 | 0.450 |
1 | 6000 | 0.390 |
1 | 5000 | 0.380 |
2 | 9809 | 0.360 |
1 | 4254 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.480 | 24 | 1 |
0.500 | 334 | 1 |
0.545 | 400 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 16.12pm 16/10/2024 (20 minute delay) ? |
Featured News
CMB (ASX) Chart |
Day chart unavailable
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online